> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Evaluating Immunosuppressive Effects in Drugs Workshop
- URL: https://www.fdaweb.com/evaluating-immunosuppressive-effects-in-drugs-workshop/
- Published: 2024-05-22T12:00:00.000Z
- Updated: 2026-09-14T14:31:29.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157033

*Federal Register* notice: FDA is announcing a 7/11 public workshop entitled “Evaluating Immunosuppressive Effects of In Utero Exposure to Drug and Biologic Products.” The workshop is intended to discuss transplacental transfer of drug and biological products with immunosuppressive properties and the potential clinical impact on the developing fetus and newborn infant, understand the gaps in knowledge, and consider innovative approaches to improve data collection. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-05-22/pdf/2024-11228.pdf?ref=fdaweb.com).